SCHEMBL832924

SCHEMBL832924

CN(C)c1ccc(CCOc2ccc(C3=NC(=Cc4ccc(OC(F)(F)F)cc4)C(=O)O3)cc2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 3/20 0.48
CSNK2B P67870 3/20 0.48
CSNK2A1 P68400 3/20 0.48
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
ALDH1A1 P00352 3/20 0.43
PLCG2 P16885 1/20 0.39
ALOX5 P09917 1/20 0.38
NOTUM Q6P988 1/20 0.37
PPARG P37231 1/20 0.37
PPARA Q07869 1/20 0.37
KDM4E B2RXH2 1/20 0.36
POLB P06746 1/20 0.36
MAPK1 P28482 1/20 0.36
F2 P00734 1/20 0.36
F10 P00742 1/20 0.36
PLG P00747 1/20 0.36
PLAU P00749 1/20 0.36
PLAT P00750 1/20 0.36
KLKB1 P03952 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL832923 1.00 CSNK2A2 (0.48) CSNK2A2CSNK2BCSNK2A1MEN1KMT2A
SCHEMBL2650490 0.81 ALDH1A1 (0.56) CSNK2A2CSNK2BCSNK2A1ALDH1A1PLCG2
SCHEMBL2650488 0.81 ALDH1A1 (0.56) CSNK2A2CSNK2BCSNK2A1ALDH1A1PLCG2
SCHEMBL4368676 0.79 CSNK2A2 (0.51) CSNK2A2CSNK2BCSNK2A1ALDH1A1PLCG2
SCHEMBL4368683 0.79 CSNK2A2 (0.51) CSNK2A2CSNK2BCSNK2A1ALDH1A1PLCG2
SCHEMBL833326 0.78 ALOX5 (0.53) CSNK2A2CSNK2BCSNK2A1MEN1KMT2A
SCHEMBL833325 0.78 ALOX5 (0.53) CSNK2A2CSNK2BCSNK2A1MEN1KMT2A
SCHEMBL6801976 0.73 PLCG2 (0.64) CSNK2A2CSNK2BCSNK2A1MEN1KMT2A
SCHEMBL5973988 0.73 PLCG2 (0.64) CSNK2A2CSNK2BCSNK2A1MEN1KMT2A
SCHEMBL17879377 0.73 PLCG2 (0.64) CSNK2A2CSNK2BCSNK2A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8497397-B2 Substituted acrylamide derivative and pharmaceutical composition comprising the same DAIICHI SANKYO COMPANY, LIMITED (JP) 2013-07-30 US disclosed
EP-1880720-B1 SUBSTITUTED ACRYLAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAIICHI SANKYO CO LTD (JP) 2013-02-13 EP disclosed
US-20120220593-A1 Substituted Acrylamide Derivative and Pharmaceutical Composition Comprising the Same DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-08-30 US disclosed
US-8143446-B2 Substituted acrylamide derivative and pharmaceutical composition comprising the same DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-03-27 US disclosed
US-20090118199-A1 SUBSTITUTED ACRYLAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAIICHI SANKYO COMPANY , LIMITED (JP) 2009-05-07 US disclosed
EP-1880720-A1 SUBSTITUTED ACRYLAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME Daiichi Sankyo Company, Limited (JP) 2008-01-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118199-A1 SUBSTITUTED ACRYLAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME ACR, NAT1, C1S CSNK2A2 1128/4885CSNK2B 1127/4885CSNK2A1 863/4885
US-20120220593-A1 Substituted Acrylamide Derivative and Pharmaceutical Composition Comprising the Same ACR, NAT1, C1S CSNK2A2 1128/4885CSNK2B 1127/4885CSNK2A1 863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.